Navigating recertification as a Physician Assistant requires weighing logistical constraints, testing preferences, and financial allocation. With the maturity of the longitudinal assessment option, PAs now face a fundamental choice: commit to the traditional single-sitting proctored exam or enroll in the quarterly, open-book PANRE-LA. While the exam registration fee for both formats remains identical at $350, the broader financial footprint: specifically how you utilize your institutional CME stipend: differs significantly.
Regardless of whether you choose the longitudinal model or the traditional testing center route, mastering the core medical content is non-negotiable. Preparing efficiently allows you to meet NCCPA standards while maximizing your professional development budget.
Course Logistics & Deliverables
To bridge the gap between exam prep and CME utilization, structured review programs provide the exact deliverables required to succeed.
- Price: Transparent tier pricing designed to fit individual or group CME budgets.
- Duration of Access: Extended online access spanning your entire study and certification window.
- Deliverables: Over 1,000 high-yield board-style questions, comprehensive study guides, and targeted rationales mapped directly to the NCCPA Blueprint.
Our flagship PANRE Review Course delivers 100 hours of Category 1 AAPA credit, fulfilling your credit requirements while solidifying your clinical knowledge base. Furthermore, clinicians looking to optimize institutional allowances can utilize our cme gift cards program. By selecting Amazon or Apple Gift Card add-ons ranging from $100 to $1,500, you can convert unused CME stipends into valuable educational hardware, textbooks, or digital tools. These are strictly structured add-on options designed to make your CME budget work harder: not promotional giveaways.
For clinicians seeking foundational reinforcement or cross-disciplinary training, our catalog also integrates seamlessly with specialized pance prep courses and targeted modules across emergency medicine, cardiology, internal medicine, and orthopedics.
Clinical Vignette Assessments
Reviewing board-style questions under simulated pressure is the most effective way to test your diagnostic fluency for either testing format. Below are two representative clinical scenarios modeled after real-world practice.
Case 1: Acute Chest Pain in the Outpatient Clinic
Your patient is a 58-year-old male with a history of hypertension and dyslipidemia who presents to your clinic complaining of intermittent, non-radiating retrosternal chest pressure triggered by physical exertion and relieved by rest. Symptoms have lasted for three months and are progressively worsening. Vital signs: BP 138/84 mmHg, HR 76 bpm, RR 16 bpm, SaO2 98% on room air. An ECG demonstrates normal sinus rhythm with no acute ST-T wave abnormalities.
Which of the following is the most appropriate next step in the outpatient evaluation of this patient?
- A) Invasive coronary angiography
- B) Computed tomography coronary angiography (CTCA)
- C) Exercise stress electrocardiography
- D) Serum high-sensitivity troponin T series
- E) Immediate hospital admission for observation
Correct Answer: C) Exercise stress electrocardiography
Explanation:
C) Exercise stress electrocardiography is the initial non-invasive test of choice for intermediate-risk patients with suspected stable ischemic heart disease who have a normal baseline ECG and are physically capable of exercising.
- Distractor A (Invasive coronary angiography) is reserved for patients with high-risk features on non-invasive testing, refractory angina, or high-probability anatomy.
- Distractor B (CTCA) is an alternative imaging modality but is generally preferred when non-invasive stress testing is equivocal or in patients with lower pre-test probability.
- Distractor D (Serum high-sensitivity troponin T series) is indicated for suspected acute coronary syndromes in the emergency setting, not stable outpatient angina.
- Distractor E (Immediate hospital admission) is unwarranted given the stable vital signs and absence of acute distress.
Case 2: Progressive Dyspnea and Peripheral Edema
Your patient is a 67-year-old female with a history of type 2 diabetes mellitus and myocardial infarction five years ago who presents with worsening exertional dyspnea, orthopnea requiring three pillows, and bilateral lower extremity swelling. Vital signs: BP 152/90 mmHg, HR 88 bpm, RR 22 bpm, SaO2 91% on room air. Physical examination reveals jugular venous distension, fine basilar rales bilaterally, and 2+ pitting edema to the mid-shins.
Which of the following pharmacologic therapies provides a documented mortality benefit in chronic heart failure with reduced ejection fraction (HFrEF)?
- A) Furosemide
- B) Digoxin
- C) Sacubitril-valsartan
- D) Amlodipine
- E) Isosorbide dinitrate without hydralazine
Correct Answer: C) Sacubitril-valsartan
Explanation:
C) Sacubitril-valsartan (an angiotensin receptor-neprilysin inhibitor) is guideline-directed medical therapy that significantly reduces morbidity and mortality in patients with HFrEF compared to ACE inhibitors alone.
- Distractor A (Furosemide) provides vital symptom relief and volume control but lacks a standalone mortality benefit.
- Distractor B (Digoxin) reduces hospitalizations for heart failure exacerbations but does not improve overall survival.
- Distractor D (Amlodipine) is a calcium channel blocker that lacks mortality benefit in HFrEF and can worsen heart failure symptoms.
- Distractor E (Isosorbide dinitrate alone) does not provide the robust mortality reduction seen with the combined hydralazine-nitrate formulation or modern neurohormonal antagonists.
Maximizing Your CME Strategy
Whether you choose the flexible, quarterly open-book format of the PANRE-LA or the single-day rigor of the traditional examination, proper preparation ensures success. By investing in our comprehensive PANRE Review Course at CME Review Courses, you earn 100 hours of Category 1 AAPA credit while mastering high-yield medical topics. Combine your purchase with our cme gift cards add-on options to make the most of your annual CME stipend today.